CPD-2828
Product Specifications
Target
IRE1
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
CPD-2828 is an orally active selective inhibitor of IRE1α, with an IC50 value of 1.2 μM. It shows potential for research into endoplasmic reticulum stress-related diseases, such as cancer and neurodegenerative disorders.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
